Transarterial embolization (TAE) demonstrates a 100% hemostasis success rate in treating ruptured hemorrhages and postablation bleeding in liver cancer patients. The 30-day survival rates were 90.91% for the rupture group and 100% for the ablation group, with 1-year survival rates of 45.45% and 85.19%, respectively. Although liver function changes occurred postoperatively, they remained comparable to controls. Monitoring alanine aminotransferase and total bilirubin is vital for early liver injury detection and timely interventions.
Journal Article by Gao W, Zhang Q (…) Yuan C et 3 al. in Transplant Proc
Copyright © 2025. Published by Elsevier Inc.